1st International Conference on Basic and Clinical ImmunoGenomics (BCI'2004)
Venue: Budapest Congress Centre
|Event Date/Time: Oct 03, 2004||End Date/Time: Oct 07, 2004|
|Registration Date: May 31, 2004|
|Early Registration Date: May 31, 2004|
|Abstract Submission Date: Apr 30, 2004|
Here, we cordially invite immunologists, molecular biologists, geneticists, bioinformatic experts studying genetic/genomic aspects of basic and medical immune response both at DNA (e.g. SNP) or gene- protein expression level to participate at the very 1st International Conference on Basic and Clinical Immunogenomics to be organized between 3-7 October, 2004, in Budapest, Hungary.
We also invite companies providing instrumentations developing robust technologies, like microarray approach, Q- and real-time PCR methods and automatic sequencing, compound libraries, chemical genomics as well as computing for bioinformatics fundamentally contributed to the revolutionary development of genomics. We encourage companies to participate and support the BCI’2004 conference with special lectures within the scientific sessions, product workshops, exhibition, leaflets or by helping scientists with travel grants.
During the 3.5-day meeting between 3-7 October) we plan to have about 5 plenary keynote lectures, 21 symposia and free posters. Moreover, plenary late-break-news sessions and educational courses in bioinformatics and genomics technologies will be organized, as well.
Major topics include: Genomics of antigen receptors and co-receptors, Immuno-Cellomics, Transplantation genomics-MHC gene variety, Functional genomics of antigen presentation and vaccination, Genomics of innate immunity , Signalling, genomics of adapter proteins and transcription factors in immune response, Complement genomics, Onco-immunogenomics, Genetic regulation of apoptosis, Infection and inflammation genomics, Hereditary immunodeficiencies, Autoimmune genomics, Dermatogenomics, Allergy genomics, Genomics of pulmonary diseases, Genomics of reproductive immunology, Genomic approach in glyco-and lipidimmunology, Chemical genomics and metabolomics in immune response, Bioinformatics in immunogenomics.
We strongly believe that this meeting will be successful and will be only the first step on the long-lasting development of immunogenomics both in basic and clinical fields.